103 related articles for article (PubMed ID: 38742251)
1. Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.
Niveau C; Sosa Cuevas E; Saas P; Aspord C
Immunology; 2024 May; ():. PubMed ID: 38742251
[TBL] [Abstract][Full Text] [Related]
2. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
[TBL] [Abstract][Full Text] [Related]
3. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
[TBL] [Abstract][Full Text] [Related]
4. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
[TBL] [Abstract][Full Text] [Related]
5. The tumour glyco-code as a novel immune checkpoint for immunotherapy.
RodrÍguez E; Schetters STT; van Kooyk Y
Nat Rev Immunol; 2018 Mar; 18(3):204-211. PubMed ID: 29398707
[TBL] [Abstract][Full Text] [Related]
6. Implications of altered O-glycosylation in tumour immune evasion.
Itano N
J Biochem; 2019 May; 165(5):387-390. PubMed ID: 30649348
[TBL] [Abstract][Full Text] [Related]
7. Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.
Bartish M; Del Rincón SV; Rudd CE; Saragovi HU
Front Immunol; 2020; 11():564499. PubMed ID: 33133075
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.
da Costa V; Freire T
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454762
[TBL] [Abstract][Full Text] [Related]
9. Glycans as shapers of tumour microenvironment: A sweet driver of T-cell-mediated anti-tumour immune response.
Fernandes Â; Azevedo CM; Silva MC; Faria G; Dantas CS; Vicente MM; Pinho SS
Immunology; 2023 Feb; 168(2):217-232. PubMed ID: 35574724
[TBL] [Abstract][Full Text] [Related]
10. Bacterial glycans and their interactions with lectins in the innate immune system.
Prado Acosta M; Lepenies B
Biochem Soc Trans; 2019 Dec; 47(6):1569-1579. PubMed ID: 31724699
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation and Antitumor Immunity.
Cadena AP; Cushman TR; Welsh JW
Int Rev Cell Mol Biol; 2019; 343():111-127. PubMed ID: 30712671
[TBL] [Abstract][Full Text] [Related]
12. Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive Macrophages.
Lopes N; Correia VG; Palma AS; Brito C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671245
[TBL] [Abstract][Full Text] [Related]
13. The Role of Glycosylation in Infectious Diseases.
Zhang XL; Qu H
Adv Exp Med Biol; 2021; 1325():219-237. PubMed ID: 34495538
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
[TBL] [Abstract][Full Text] [Related]
15. Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis.
Shu L; Lin S; Zhou S; Yuan T
Platelets; 2024 Dec; 35(1):2315037. PubMed ID: 38372252
[TBL] [Abstract][Full Text] [Related]
16. The Role of Glycosylation in Melanoma Progression.
De Vellis C; Pietrobono S; Stecca B
Cells; 2021 Aug; 10(8):. PubMed ID: 34440905
[TBL] [Abstract][Full Text] [Related]
17. Tumour associated glycans: A route to boost immunotherapy?
Scott E; Elliott DJ; Munkley J
Clin Chim Acta; 2020 Mar; 502():167-173. PubMed ID: 31870793
[TBL] [Abstract][Full Text] [Related]
18. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
19. Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors.
Busold S; Nagy NA; Tas SW; van Ree R; de Jong EC; Geijtenbeek TBH
Front Immunol; 2020; 11():134. PubMed ID: 32117281
[TBL] [Abstract][Full Text] [Related]
20. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.
Pinho SS; Alves I; Gaifem J; Rabinovich GA
Cell Mol Immunol; 2023 Oct; 20(10):1101-1113. PubMed ID: 37582971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
